The quadrivalent Human Papilloma Virus (HPV) vaccine will be available at the affordable price range of ₹ 200-400, too
Every year in India, 122,844 women are diagnosed with cervical cancer and 67,477 die from the disease.
New Delhi: Serum Institute has requested the Indian health ministry and Central Drugs Standard Control Organisation...
New Delhi: CEO of the Serum Institute of India(SII), Adar Poonawalla on Saturday said that 16 European countries have...
"Covisheld is the most affordable Covid-19 vaccine available in the market today" says SII
Serum Institute of India, on Sunday, filed a defamation suit of 100 crores against the 40-year-old who took part in the...
In an interview with NDTV, Serum Institute of India (SII) CEO Adar Poonawalla announced that Covishield vaccine...
New Delhi: The suspension of a potential vaccine by UK-based AstraZeneca has raised concerns among the scientific...